Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis

References

Page 1

	Year	Citations
Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine Joel E. Gallant, R D Moore, D. D. Richman, The Journal of Infectious Diseases	1992	531
Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients Alejo Erice, Sunwen Chou, Karen K. Biron, New England Journal of Medicine TransplantationViral PersistenceHuman RetrovirusCmv RetinitisImmunology	1989	408
Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS Stephen A. Spector, George McKinley, Jacob Lalezari, New England Journal of Medicine	1996	310
Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDS William Drew, David Ives, Jacob Lalezari, New England Journal of Medicine	1995	287
Use of Ganciclovir to Treat Serious Cytomegalovirus Infections in Patients with AIDS O. L. Laskin, Celine M. Stahl‐Bayliss, Concetta M. Kalman, The Journal of Infectious Diseases New York SearchImmunodeficienciesJournal Article UseImmunologyAntiviral Response	1987	153
Sensitivity of Clinical Isolates of Human Cytomegalovirus to 9-(1,3-Dihydroxy-2-Prop.oxymethyl)Guanine S. A. Plotkin, William Drew, Donna Felsenstein, The Journal of Infectious Diseases Diagnostic VirologyDonna Felsenstein SearchViral DiagnosticsImmunodeficienciesPathogenesis	1985	137
Clinical Pharmacokinetics of Ganciclovir in Patients with Normal and Impaired Renal Function Jean‐Pierre Sommadossi, Rae Bevan, Teck L. Ling, Clinical Infectious Diseases ImmunologyPharmacotherapyAntiviral DrugBiexponential DecayPharmacokinetics	1988	112
Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication Michael J. Tocci, Taylor Livelli, Helen C. Perry, Antimicrobial Agents and Chemotherapy Cytomegalovirus DnaViral ReplicationCell DivisionNatural SciencesImmunology	1984	108
Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study Stephen A. Spector, David F. Busch, Stephen Follansbee, The Journal of Infectious Diseases	1995	106
Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients Roger D. Anderson, Kay Griffy, Donald Jung, Clinical Therapeutics Treatment And PreventionNeurovirologyMedicineAntiviral Drug DevelopmentAntiviral Therapy	1995	89

Page 1